FACIT backed Radiant Biotherapeutics announces closing of $8M seed round for cancer therapies Posted on April 25, 2023 (July 24, 2023) by Ricky April 25, 2023 – Emerging from stealth mode, Radiant’s financing enables the Company to continue rapidly advancing its Multabodies that have application across multiple diseases including cancer.